{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:53:51Z","timestamp":1698749631466},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,12,17]],"date-time":"2007-12-17T00:00:00Z","timestamp":1197849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,12,17]],"date-time":"2007-12-17T00:00:00Z","timestamp":1197849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/sj.bmt.1705947","type":"journal-article","created":{"date-parts":[[2007,12,17]],"date-time":"2007-12-17T12:16:07Z","timestamp":1197893767000},"page":"621-625","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Safe administration of oral BU twice daily during conditioning for stem cell transplantation in a paediatric population: a comparative study between the standard 4-dose and a 2-dose regimen"],"prefix":"10.1038","volume":"41","author":[{"given":"K","family":"Mellgren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Fasth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Abrahamsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Winiarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Ringd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,17]]},"reference":[{"key":"BF1705947_CR1","first-page":"399","volume":"15","author":"M Hassan","year":"1987","unstructured":"Hassan M, Ehrsson H . Urinary metabolites of busulfan in the rat. Drug Metab Dispos 1987; 15: 399\u2013402.","journal-title":"Drug Metab Dispos"},{"key":"BF1705947_CR2","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","volume":"104","author":"A Srivastava","year":"2004","unstructured":"Srivastava A, Poonkuzhali B, Shaji RV, George B, Mathews V, Chandy M et al. Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclussive disease in bone marrow transplantation. Blood 2004; 104: 1574\u20131577.","journal-title":"Blood"},{"key":"BF1705947_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cca.2005.12.011","volume":"368","author":"M Kusama","year":"2006","unstructured":"Kusama M, Kubota T, Matsukura Y, Matsuno K, Ogawa S, Kanda Y et al. Influence of glutathione S-transferase A1 polymorphism on the pharmacokinetics of busulfan. Clin Chim Acta 2006; 368: 93\u201398.","journal-title":"Clin Chim Acta"},{"key":"BF1705947_CR4","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood.V84.7.2144.2144","volume":"84","author":"M Hassan","year":"1994","unstructured":"Hassan M, Ljungman P, Bolme P, Ringd\u00e8n O, Syruckov\u00e1 Z, B\u00e9k\u00e0ssy A et al. Busulfan bioavaliability. Blood 1994; 84: 2144\u20132150.","journal-title":"Blood"},{"key":"BF1705947_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/01.ftd.0000180226.04137.75","volume":"28","author":"JM Bullock","year":"2006","unstructured":"Bullock JM, Smith PF, Booker BM, Loughner J, Capozzi D, McCarthy Jr PL et al. Development of a pharmacokinetic and Bayesian optimal sampling model for individualization of oral busulfan in hematopoietic stem cell transplantation. Ther Drug Monit 2006; 28: 62\u201366.","journal-title":"Ther Drug Monit"},{"key":"BF1705947_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2165\/00003088-200039020-00005","volume":"39","author":"JS McCune","year":"2000","unstructured":"McCune JS, Gibbs JP, Slattery JT . Plasma concentration monitoring of busulfan: does it improve clinical outcome? Clin Pharmacokinet 2000; 39: 155\u2013165.","journal-title":"Clin Pharmacokinet"},{"key":"BF1705947_CR7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/sj.bmt.1703264","volume":"28","author":"AM Bolinger","year":"2001","unstructured":"Bolinger AM, Zangwill AB, Slattery JT, Risler LJ, Sultan DH, Glidden DV et al. Target dose adjustment of busulfan in pediatric patients undergoing bone marrow transplantation. Bone Marrow Transplant 2001; 28: 1013\u20131018.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705947_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/sj.bmt.1703229","volume":"28","author":"M Sandstr\u00f6m","year":"2001","unstructured":"Sandstr\u00f6m M, Karlsson MO, Ljungman P, Hassan Z, Jonsson EN, Nilsson C et al. Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients. Bone Marrow Transplant 2001; 28: 657\u2013664.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705947_CR9","first-page":"843","volume":"18","author":"M Hassan","year":"1996","unstructured":"Hassan M, Fasth A, Gerritsen B, Haraldsson A, Syruckov\u00e1 Z, van den Berg H et al. Busulphan kinetics and limited sampling model in children with leukemia and inherited disorders. Bone Marrow Transplant 1996; 18: 843\u2013850.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705947_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/sj.bmt.1702371","volume":"25","author":"AM Bolinger","year":"2000","unstructured":"Bolinger AM, Zangwill AB, Slattery JT, Glidden D, DeSantes K, Heyn L et al. An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease. Bone Marrow Transplant 2000; 25: 925\u2013930.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705947_CR11","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1182\/blood.V89.8.3055","volume":"89","author":"JT Slattery","year":"1997","unstructured":"Slattery JT, Clift RA, Buckner CD, Radich J, Storer B, Bensinger WI et al. Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood 1997; 89: 3055\u20133060.","journal-title":"Blood"},{"key":"BF1705947_CR12","first-page":"31","volume":"16","author":"JT Slattery","year":"1995","unstructured":"Slattery JT, Sanders JE, Buckner CD, Schaffer RL, Lambert KW, Langer FP et al. Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant 1995; 16: 31\u201342.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705947_CR13","doi-asserted-by":"publisher","first-page":"881","DOI":"10.7326\/0003-4819-112-11-881_1","volume":"112","author":"G Vassal","year":"1990","unstructured":"Vassal G, Hartmann O, Benhamou E . Busulfan and veno-occlussive disease of the liver. Ann Intern Med 1990; 112: 881.","journal-title":"Ann Intern Med"},{"key":"BF1705947_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00694339","volume":"25","author":"LB Grochow","year":"1989","unstructured":"Grochow LB, Jones RJ, Brundrett RB, Braine HG, Chen TL, Saral R et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1989; 25: 55\u201361.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1705947_CR15","first-page":"225","volume":"17","author":"SP Dix","year":"1996","unstructured":"Dix SP, Wingard JR, Mullins RE, Jerkunica I, Davidson TG, Gilmore CE et al. Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Transplant 1996; 17: 225\u2013230.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705947_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.bmt.1704707","volume":"35","author":"J Zwaveling","year":"2005","unstructured":"Zwaveling J, Bredius RG, Cremers SC, Ball LM, Lankester AC, Teepe-Twiss IM et al. Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity. Bone Marrow Transplant 2005; 35: 17\u201323.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705947_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778\u2013783.","journal-title":"Transplantation"},{"key":"BF1705947_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BF1705947_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00277-005-1076-7","volume":"84","author":"K Mellgren","year":"2005","unstructured":"Mellgren K, Fasth A, Saalman R, Olausson M, Abrahamsson J . Liver transplantation after stem cell transplantation with the same living donor in a monozygotic twin with acute myeloid leukemia. Ann Hematol 2005; 84: 755\u2013757.","journal-title":"Ann Hematol"},{"key":"BF1705947_CR20","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/00043426-200212000-00013","volume":"24","author":"U Reiss","year":"2002","unstructured":"Reiss U, Cowan M, McMillan A, Horn B . Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients. J Pediatr Hematol Oncol 2002; 24: 746\u2013750.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BF1705947_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB Mc Donald","year":"1984","unstructured":"Mc Donald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED . Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116\u2013122.","journal-title":"Hepatology"},{"key":"BF1705947_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1055\/s-2007-1007173","volume":"18","author":"LD DeLeve","year":"1998","unstructured":"DeLeve LD . Glutathione defense in non-parenchymal cells. Semin Liver Dis 1998; 18: 403\u2013413.","journal-title":"Semin Liver Dis"},{"key":"BF1705947_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/sj.bmt.1704697","volume":"35","author":"A Jenke","year":"2005","unstructured":"Jenke A, Freiberg-Richter J, Wilhelm S, Freund M, Renner UD, Bornh\u00e4user M et al. Accidental busulfan overdose during conditioning for stem cell transplantation. Bone Marrow Transplant 2005; 35: 125\u2013128.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705947_CR24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/00007890-198804000-00035","volume":"45","author":"FB Petersen","year":"1988","unstructured":"Petersen FB, Sanders JE, Storb R, Bensinger WI, Clift RA, Buckner CD . Inadvertent administration of a greater-than-usual pre-marrow transplant dose of busulfan\u2014report of a case. Transplantation 1988; 45: 821\u2013822.","journal-title":"Transplantation"},{"key":"BF1705947_CR25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.bmt.1702801","volume":"27","author":"J Stein","year":"2001","unstructured":"Stein J, Davidovitz M, Yaniv I, Ben-Ari J, Gamzu Z, Hoffer E et al. Accidental busulfan overdose: enhanced drug clearance with hemodialysis in a child with Wiskott\u2013Aldrich syndrome. Bone Marrow Transplant 2001; 27: 551\u2013553.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705947_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/sj.bmt.1702377","volume":"25","author":"M Hassan","year":"2000","unstructured":"Hassan M, Ljungman P, Ringd\u00e9n O, Hassan Z, Oberg G, Nilsson C et al. The effect of busulphan on the pharmacokinetics of cyclophoshamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity. Bone Marrow Transplant 2000; 25: 915\u2013924.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705947_CR27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1046\/j.1365-2141.2001.03044.x","volume":"114","author":"US Schuler","year":"2001","unstructured":"Schuler US, Renner UD, Kroschinsky F, Johne C, Jenke A, Naumann R et al. Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation. Br J Haematol 2001; 114: 944\u2013950.","journal-title":"Br J Haematol"},{"key":"BF1705947_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.bmt.1705252","volume":"37","author":"H Takama","year":"2006","unstructured":"Takama H, Tanaka H, Nakashima D, Ueda R, Takaue Y . Population pharmacokinetics of intravenous busulfan in patients undergoing hematopoietic stem cell population. Bone Marrow Transplant 2006; 37: 345\u2013351.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705947.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705947","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705947.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:49:50Z","timestamp":1648082990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,17]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["BF1705947"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705947","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,17]]},"assertion":[{"value":"22 March 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}